At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is October 2023’s round-up.
Investments
Biorithm secures $3.5M in Series A funding for its obstetric remote monitoring solution.
Sustainable femcare brand Yoni raises €2.3M for European expansion.
Maia Oncology secures $4.25M to reinvent cancer care with an initial focus on breast cancer.
Freya Biosciences secures $38M in Series A funding to advance women's reproductive immunotherapies.
Pulmonary emobolism startup Flow Medical adds $2M in funding.
Orchid introduces whole genome sequencing reports for embryos after raising $12M in funding.
Hey Freya secures $500K in angel funding to advance women's wellness through doctor-formulated supplements.
Poland-based MIM Fertility secures $2M in seed funding to advance its AI-enabled IVF solutions.
Acquisitions
Lunit targets US market with $193M acquisition of AI-enabled breast cancer detection platform Volpara.
Perios pain relief brand Somedays acquires cycle cyre B-Corp Aisle.
Aditxt enters women's health market with $100M Evofem acquisition.
Imaware acquires Binx Health's consumer testing business, expanding its reach in STI health screening.
